Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aithal, P G
Right arrow Articles by Day, C P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aithal, P G
Right arrow Articles by Day, C P
Related Collections
Right arrow Non-therapeutic
Right arrow Liver, including hepatitis
Right arrowRelated Article
Gut 1999;44:731-735 ( May )

The natural history of histologically proved drug induced liver disease

P G Aithal, C P Day

Centre for Liver Research, The Medical School, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK

Correspondence to: Dr Day.

Accepted for publication 17 December 1998

BACKGROUND---The long term outcome of drug related liver disease is unknown.
AIMS---To study the natural history of histologically proved drug induced hepatotoxicity.
METHODS---110 patients with liver biopsies coded either as drug induced liver disease or hepatitis/cholestasis of unknown aetiology were identified from hospital records 1978-1996. Review of case notes and histology identified 44 patients with definite drug induced hepatotoxicity. Forty surviving patients were invited to attend a follow up clinic. History, examination, full liver screen, and isotope and ultrasound liver scans were repeated in all patients. Repeat liver biopsies were offered to patients with abnormal liver tests.
RESULTS---Presentation at index biopsy was jaundice in 24 patients, abnormal liver tests in 17, and hepatic failure in three. Antibiotics (n=13) and non-steroidal anti-inflammatory drugs (n=11) were the most common drugs implicated. Initial histology showed acute hepatitis in six, chronic hepatitis in 20, and cholestasis in 18. At 1-19 years (median 5 years) follow up, 13/33 (39%) patients had persistent significant abnormalities in their liver blood tests and/or scans. Three of the five repeat liver biopsies performed showed significant abnormalities. Factors predicting persistence or development of chronic liver disease were fibrosis and continued exposure to the drug.
CONCLUSIONS---Drugs should be considered in the differential diagnosis of abnormal liver function and/or histology, as failure to withdraw the offending drug is associated with a high risk of persistent liver damage.
(Gut 1999;44:731-735)

Keywords: drugs;  chronic active hepatitis;  toxic hepatitis;  diclofenac


© 1999 by Gut

Related Article

JournalScan
Gut 2007 56: 416. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
QJMHome page
N. O'connor, P.I. Dargan, and A.L. Jones
Hepatocellular damage from non-steroidal anti-inflammatory drugs
QJM, November 1, 2003; 96(11): 787 - 791.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. M. Studdert, M. M. Mello, and T. A. Brennan
Medical Monitoring for Pharmaceutical Injuries: Tort Law for the Public's Health?
JAMA, February 19, 2003; 289(7): 889 - 894.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. D. May, J. H. Lefkowitch, M. T. Kram, and D. E. Rubin
Mixed Hepatocellular-Cholestatic Liver Injury after Pioglitazone Therapy
Ann Intern Med, March 19, 2002; 136(6): 449 - 452.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
G. P Aithal, M. D Rawlins, and C. P Day
Accuracy of hepatic adverse drug reaction reporting in one English health region
BMJ, December 11, 1999; 319(7224): 1541 - 1541.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & British Society of Gastroenterology